Using data from the Study to Evaluate the Efficacy and Safety of Erenumab in Migraine Prevention, researchers were able to analyze the efficacy of erenumab at ≥50%, ≥75%, and 100% thresholds for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback